I. Shalaby
King Abdullah Medical City(SA)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer-related Molecular Pathways, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial(2018)229 cited
- → A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer(2010)65 cited
- → Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9(2015)24 cited
- → Effect of pile cap elevation below ground surface on lateral resistance of pile groups-experimental study(2009)9 cited
- → Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group(2008)8 cited
- → Abstract OT3-04-01: BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC)(2017)4 cited
- → Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib(2019)2 cited
- → Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer(2004)1 cited
- → Emergency oncology admissions during COVID-19 pandemic: a major institution experience from Saudi Arabia(2021)1 cited
- → 904 poster BEXXAR PROTOCOL CP98-020: RADIO-IMMUNOTHERAPY RESULTS WITH I-131 LABELED ANTIBODY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA: MEDIAN 5-YEAR RESULTS IN 70 CASES(2011)